BigData@Heart is breaking new ground in the development of treatment for millions of patients with heart disease in Europe.

The objective of BigData@Heart is to develop a data-driven translational research platform of unparalleled scale and phenotypical resolution, with the aim to improve patient outcomes and reduce the societal burden of atrial fibrillation, heart failure and acute coronary syndrome.

The 19 partners of the BigData@Heart consortium, coming from academia, medical associations, the pharmaceutical industry, SMEs and patient organisations are:

University Medical Center Utrecht
Charité - Universitätsmedizin Berlin
European Society of Cardiology
European Heart Network
University College London
University of Cambridge
International Consortium for Health Outcomes Measurement
Fundación para la investigación del Hospital Clinico de la Comunidad Valenciana
Karolinska Institutet
Universitätsklinikum Hamburg-Eppendorf
MLC Foundation
University of Birmingham
Uppsala Clinical Research Center, Uppsala University
BAYER
NOVARTIS
SERVIER
SomaLogic
Vifor Pharma
The Hyve

Please click here for the BigData@Heart press release on this project.

Launched in March 2017, BigData@Heart is a five-year project of the Innovative Medicines Initiative (IMI), a public-private initiative between the European Union and the pharmaceutical industry association EFPIA.

BigData@Heart aims to develop a data-driven translational research platform towards improving patient outcomes and therefore reducing the societal burden of Atrial Fibrillation (AF), Acute Coronary Syndrome (ACS) and Heart Failure (HF) in Europe.